ÂÜÀòÂÒÂ×

Stéphane Temmerman is the Director and Head of Preclinical Immunomodulation Research at GSK, where they provide strategic and managerial leadership in the field of immunology. Previously, Stéphane served as a Principal Investigator at the Institute for Medical Immunology, focusing on novel vaccine adjuvant candidates and mentoring PhD students. Stéphane holds a PhD in Biomedical Sciences from Université libre de Bruxelles, where their research on a mycobacterial vaccine candidate was published in Nature Medicine. Their extensive experience includes postdoctoral work at the National Institutes of Health, specializing in immune deficiency disorders.